CLINICAL TRIALS PROFILE FOR CALCITONIN SALMON RECOMBINANT
✉ Email this page to a colleague
All Clinical Trials for CALCITONIN SALMON RECOMBINANT
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00004358 ↗ | Phase II Study of Calcitonin for Tumoral Calcinosis | Completed | Ann & Robert H Lurie Children's Hospital of Chicago | Phase 2 | 1992-11-01 | OBJECTIVES: I. Determine whether intermittent, long-term, subcutaneous administration of calcitonin increases phosphaturia, reduces hyperphosphatemia, and increases intact parathyroid hormone levels in patients with tumoral calcinosis. II. Determine whether calcitonin reduces or prevents tumor recurrence. III. Determine whether hyperphosphatemia abolishes the normal circadian pattern of serum phosphorus. IV. Determine how repetitive calcitonin administration alters the biochemical markers of bone metabolism in osteopenic patients with tumoral calcinosis. |
| NCT00004358 ↗ | Phase II Study of Calcitonin for Tumoral Calcinosis | Completed | National Center for Research Resources (NCRR) | Phase 2 | 1992-11-01 | OBJECTIVES: I. Determine whether intermittent, long-term, subcutaneous administration of calcitonin increases phosphaturia, reduces hyperphosphatemia, and increases intact parathyroid hormone levels in patients with tumoral calcinosis. II. Determine whether calcitonin reduces or prevents tumor recurrence. III. Determine whether hyperphosphatemia abolishes the normal circadian pattern of serum phosphorus. IV. Determine how repetitive calcitonin administration alters the biochemical markers of bone metabolism in osteopenic patients with tumoral calcinosis. |
| NCT00239889 ↗ | Efficacy and Safety of Salmon Calcitonin Nasal Spray in Improving Muscle Strength and Reducing Pain After Forearm Fracture in Postmenopausal Women | Completed | Novartis | Phase 4 | 2002-03-01 | Calcitonin has been used for many years for treating osteoporosis in postmenopausal women, and it has been shown that calcitonin reduces pain after spine and hip fracture in women with osteoporosis. Therefore, this study assesses the safety and efficacy of salmon calcitonin nasal spray on muscle strength after a forearm fracture, pain, quality of life and fracture healing in postmenopausal women. |
| NCT00372099 ↗ | Bone Microstructure in Nasal Salmon Calcitonin Treated Postmenopausal Women | Completed | Rene Rizzoli | Phase 3 | 2007-01-01 | Calcitonin has been used for many years for treating osteoporosis in postmenopausal women. Recent data from the 2 years placebo-controlled QUEST study have shown a preservation of microarchitecture as measured by high resolution MRI in postmenopausal women with prevalent vertebral fractures at baseline.This pilot study should provide additional new insights in the mode of action of nasal calcitonin, on structural changes as measured by high resolution peripheral CT, and on the comparison between weight bearing and non weight bearing bones in postmenopausal women. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CALCITONIN SALMON RECOMBINANT
Condition Name
Clinical Trial Locations for CALCITONIN SALMON RECOMBINANT
Trials by Country
Clinical Trial Progress for CALCITONIN SALMON RECOMBINANT
Clinical Trial Phase
Clinical Trial Sponsors for CALCITONIN SALMON RECOMBINANT
Sponsor Name
